Keyphrases
Immune Response
100%
Vaccine Candidate
100%
B Cells
100%
Neutralizing Antibodies
100%
Immunization
100%
Cell-to-cell
100%
Nonhuman Primate
100%
T Cell Response
100%
Immune Assay
100%
Inactivated SARS-CoV-2 Vaccine
100%
Vaccine Development
50%
CD4+
50%
Macaca Fascicularis
50%
Post-challenge
50%
Adverse Reactions
50%
CD8+ Cells
50%
Indonesia
25%
COVID-19
25%
Quantitative PCR
25%
Sodium Chloride
25%
East Java Indonesia
25%
Immunogenicity
25%
Immune Cells
25%
Sham
25%
Clinical Signs
25%
COVID-19 Infection
25%
ELISA Assay
25%
Inflammation Response
25%
Pandemic Control
25%
Intramuscular Injection
25%
CD8+
25%
SARS-CoV-2 Vaccine
25%
Health Resources
25%
Vaccine Dose
25%
Nasopharyngeal Sample
25%
Effective Metric
25%
Virus Neutralization
25%
COVID-19 Mortality
25%
COVID-19 Vaccination Coverage
25%
COVID-19 Pandemic Management
25%
Efficient Measures
25%
Cell Stimulation
25%
Human Vaccines
25%
National Stability
25%
Antibody Induction
25%
SARS-CoV-2 Inactivated Vaccines
25%
Immunology and Microbiology
B Cell
100%
Immune Response
100%
Neutralizing Antibody
100%
COVID-19
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
T Cell
100%
CD4
50%
Macaca fascicularis
50%
CD8+ Cell
50%
Immunogenicity
25%
Immunocompetent Cell
25%
ELISA
25%
Inflammation Response
25%
Neutralization
25%
CD8
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
Inactivated Vaccine
25%
Cell Stimulation
25%
Pharmacology, Toxicology and Pharmaceutical Science
COVID-19 Vaccine
100%
Neutralizing Antibody
100%
CD8 Antigen
75%
Vaccine Development
50%
Adverse Event
50%
Macaca fascicularis
50%
Inflammation
25%
Enzyme-Linked Immunosorbent Assay
25%
Infection
25%
Immunogenicity
25%
SARS Coronavirus
25%
Clinical Study
25%
Inactivated Vaccine
25%
Veterinary Science and Veterinary Medicine
B Cell
100%
T Cell
100%
SARS Coronavirus
100%
COVID-19
100%
CD4
50%
CD8+ Cell
50%
Infectious Disease
25%
Clinical Signs
25%
Intramuscular Drug Administration
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%